From Startups to Market Leaders
EQT Private Capital Europe & North America applies a thematic investment approach and invests in high-quality companies in healthcare, technology, industrial technology, and services. It has deep experience in owning companies in every stage of their development, investing from early-stage ventures to large-cap buyouts.
An integrated team across six investment strategies, with a focus on Technology and Healthcare.
The Private Capital Europe & North America strategies are divided into Private Equity (EQT Equity and EQT Future), early-stage technology (EQT Ventures and EQT Growth) and early-stage healthcare (EQT Life Sciences and EQT Healthcare Growth). The teams share knowledge and experience across the entire platform, enabling EQT Private Capital Europe & North America to drive sustainable growth, operational excellence and market leadership in its portfolio companies.
What We Invest In
Healthcare
Technology
Services
Industrial Technology
Explore Our Portfolio
See all
A leading global skincare company
Focused on achieving superior, science-based outcomes for patients and consumers, Galderma is advancing dermatology for every skin story.
Sector
Healthcare
Country
Switzerland
Responsible advisor
Michael Bauer
Entry
2019
Web
One of Europe’s largest online C2C platforms dedicated to second-hand fashion
Founded in 2008 and headquartered in Vilnius, Lithuania, Vinted operates in over 10 markets, and has become the largest online C2C marketplace in second-hand fashion across Europe.
Sector
Consumer
Country
Lithuania
Responsible advisors
Carolina Brochado
Entry
2021
Web
A leading global specialist in pest control
The company operates in 18 countries across Europe, Asia Pacific, and the US, serving nearly three million customers. Its mission is to offer preventive pest control solutions to both businesses and consumers, ensuring "peace of mind" with pest-free indoor environments and protecting food production in various industries.
Sector
Services
Country
Sweden
Responsible advisor
Per Franzén
Entry
2012
A Swedish biotech company developing immunoassays for life science research
Since 1986, Mabtech’s mission has been to aid research by providing the global scientific community with innovative tools. To that end, the company generates and produces a wide range of monoclonal antibodies, kits, peptide pools, and instruments for in vitro applications.
Sector
Biotech
Country
Sweden
Responsible advisor
Isabel de Paoli
Entry
2024
Web
Androids to benefit society and meet the world’s labor demand
1X is an AI and robotics company, with roots in Norway and Silicon Valley. The team is building a world where you do more of what you love, while your humanoid companions handle the rest. 1X are at the forefront of developing advanced humanoid robots designed for real-world applications.
Sector
AI Robotics
Country
Norway
Fund
EQTV III
Entry
2024
Web
Innovations that improve the quality of life for people with rare diseases.
Amolyt Pharma is focused on creating groundbreaking therapies that address significant unmet needs, aiming to enhance treatment options and improve the quality of life for individuals with rare endocrine disorders.
Sector
Healthcare
Country
France
Fund
LSP 6
Entry
2019
Spotlight OnPrivate Capital
Meet Our People
Our EQT Private Capital team leverages deep expertise to foster sustainable growth and operational excellence in portfolio companies.
See the full team
Do You Want to Know More?
We are eager to explore how we can achieve great things together.
Exclusive News and Insights
Press the button below to sign up for our EQT newsletters.